A physiological role of interferon (IFN)-β derived from tumor: Tumor growth of a mouse bladder carcinoma line MBT-2 is partially suppressed by autocrine IFN-β

Cancer Letters

Volumn 113, Issue 1-2, 1997, Pages 159-164

  Kawabata, Kenji ^a   Okamoto, Sachiko ^a   Takakura, Yoshinobu ^a   Hashida, Mitsuru ^a   Hashimura, Takayuki ^b   Watanabe, Yoshihiko ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION HIMEJI MEDICAL CENTER   (Japan)

Author keywords

Bladder tumor; Immunogenicity; Interferon ; Tumor suppression

Indexed keywords

BETA INTERFERON; INTERFERON ANTIBODY; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER CARCINOMA; CANCER CELL CULTURE; CANCER INHIBITION; CANCER SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INTERFERON-BETA; MICE; MICE, INBRED C3H; NEOPLASM TRANSPLANTATION; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

ANIMALIA;

EID: 0031586740     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(96)04594-6     Document Type: Article

References (24)

1. [1] Mann, E.A., Spiro, J.D., Chen, L.L. and Kreutzer, D.L. (1992) Cytokine expression by head and neck squamous cell carcinomas, Am. J. Surg., 164, 567-573.
2. [2] Takeda, K., Fujii, N., Nitta, Y., Sakihara, H., Nakayama, K., Rikiishi, H. and Kumagai, K. (1991) Murine tumor cells metastasizing selectivity in the liver: ability to produce hepatocyte-activating cytokines interleukin-1 and/or -6, Jpn. J. Cancer Res., 82, 1299-1308.
3. [3] Lichtenstein, A., Berenson, J., Norman, D., Chang, M.P. and Carlile, A. (1989) Production of cytokines by bone marrow cells obtained from patients with multiple myeloma, Blood, 74, 1266-1273.
4. [4] Huang, M., Wang, J., Lee, P., Sharma, S., Mao, J.T., Meissner, H., Uyemura, K., Modlin, R., Wollman, J. and Dubinett, S.M. (1995) Human non-small cell lung cancer cells express a type 2 cytokine pattern, Cancer Res., 55, 3847-3853.
5. [5] Feng, D., Nagy, J.A., Hipp, J., Dvorak, H.F. and Dvorak, A.M. (1996) Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin, J. Exp. Med., 183, 1981-1986.
6. [6] Aguet, M., Dembic, Z. and Merlin, G. (1988) Molecular cloning and expression of the human interferon-γ receptor, Cell, 55, 273-280.
7. [7] Uze, G., Lutfalla, G. and Gresser, I. (1990) Genetic transfer of a functional human interferon-α receptor into mouse cells: cloning and expression of its cDNA, Cell, 60, 225-234.
8. [8] Darnell, J.E., Kerr, I.M. and Stark, G,M. (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins, Science, 264, 1415-1421.
9. [9] DeMaeyer, E. and DeMaeyer-Guinard, J. (1988) Interferons and Other Regulatory Cytokines, p. 488. Wiley, New York.
10. [10] Lengyel, P. (1982) Biochemistry of interferons and their actions, Annu. Rev. Biochem., 51, 251-282.
11. [11] Sen, G.C. and Lengyel, P. (1992) The interferon system: a bird's eye view of its biochemistry, J. Biol. Chem., 267, 5017-5020.
12. [12] Hiura, M., Hashimura, T., Watanabe, Y., Kuribayashi, K. and Yoshida, O. (1994) Induction of specific anti-tumor immunity by interferon-γ gene-transferred murine bladder carcinoma MBT-2, Folia Biol., 40, 1-13.
13. [13] Watanabe, Y., Kuribayashi, K., Miyatake, S., Nishihara, K., Nakayama, E., Taniyama, T. and Sakata, T. (1989) Exogenous expression of mouse interferon γ cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity, Proc. Natl. Acad. Sci. USA, 86, 9456-9460.
14. [14] Watanabe, Y. and Kawade, Y. (1987) In: Lymphokines and Interferons: a Practical Approach, pp. 1-14. Editors: M.J. Clemens, A.G. Morris and J.M. Gearing. Elsevier, Amsterdam.
15. [15] Kawade, Y. and Watanabe, Y. (1987) In: The Biology of The Interferon System, pp. 197-201. Editors: K. Cantell and H. Schellekens. Nijhoff, Dordrecht.
16. [16] Spitalny, G.L. and Havell, E.A. (1984) Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities, J. Exp. Med., 159, 1560-1565.
17. [17] Chomczynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem., 162, 156-159.
18. [18] Heyman, M., Grander, D., Brondum-Nielsen, K., Cederblad, B., Liu, Y., Xu, B. and Einhorn, S. (1994) Interferon system defects in malignant T-cells, Leukemia, 8, 425-434.
19. [19] Linge, C., Gewert, D., Rossmann, C., Newton Bishop, J.A. and Scott Crowe, J. (1995) Interferon system defects in human malignant melanoma, Cancer Res., 55, 4099-4104.
20. [20] Olopade, O.I., Jenkins, R.B., Ransom, D.T., Malik, K., Pomykala, H., Nobori, T., Cowan, J.M., Rowley, J.D. and Diaz, M.O. (1992) Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas, Cancer Res., 52, 2523-2529.
21. [21] Von Wusscow, P., Block, B., Hartmann, F. and Deicher, H. (1988) Intralesional interferon-α therapy in advanced malignant melanoma, Cancer, 61, 1071-1074.
22. [22] Gresser, I., Belardelli, F., Maury, C., Maunory, M.-T. and Tovey, M.G. (1983) Injection of mice with antibody to interferon enhances the growth of transplantable murine tumors, J. Exp. Med., 158, 2095-2107.
23. [23] Watanabe, Y. and Sakata, T. (1988) Highly efficient action of autocrine mouse interferon-γ expressed via a retroviral vector, Eur. J. Immunol., 18, 1627-1630.
24. + T cell-mediated tumor rejection and development of antitumor immunity, J. Immunol., 153, 4604-4615.